(Q77742224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Risk reduction in the intensive care unit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

S Saint

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M A Matthay

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

515-523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

Intensive care unit survival of patients with systemic illness

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Economic analysis of the intensive care unit: a dilemma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

The natural history and epidemiology of venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Epidemiology and natural history of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

7 January 2021

Venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of venous thromboembolism after general surgery. Cost-effectiveness analysis of alternative approaches to prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prophylaxis of venous thromboembolism: analysis of cost effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Risk factors for pulmonary embolism. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Epidemiology of Venous Thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

7 January 2021

Hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

High risk of the critically ill for venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Low-dose heparin after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of deep vein thrombosis in medical patients by low-dose heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prophylaxis against postoperative pulmonary embolism and deep-vein thrombosis by low-dose heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Low-dose heparin prophylaxis against fatal pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Intermittent pneumatic compression for the prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Utilization of Venous Thromboembolism Prophylaxis in the Medical Intensive Care Unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Physician practices in the prevention of venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Hemorrhagic complications of anticoagulant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Stress ulcer prophylaxis: in whom? With what?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Upper gastrointestinal hemorrhage. Comparison of the causes and prognosis in primary and secondary bleeders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Predictors of mortality in hospitalized patients with secondary upper gastrointestinal haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Bleeding peptic ulcer occurring in hospitalized patients: analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Critical care pharmacotherapy. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Side effects of stress bleeding prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Effects of gastric alkalization on bacterial colonization in critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Antibacterial activity of sucralfate in human gastric juice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Infectious complications of indwelling vascular catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Consequences of intravascular catheter sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Excess mortality in critically ill patients with nosocomial bloodstream infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Intravenous and central catheter infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Sepsis from triple- vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Use of triple-lumen subclavian catheters for administration of total parenteral nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prospective evaluation of single and triple lumen catheters in total parenteral nutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Risk of infection accompanying the use of single-lumen vs double-lumen subclavian catheters: a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Comparative Efficacy of Alternative Hand-Washing Agents in Reducing Nosocomial Infections in Intensive Care Units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A prospective randomized comparison of an attached silver-impregnated cuff to prevent central venous catheter-associated infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Pulmonary artery flow-guided catheters in the perioperative period. Indications and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

A prospective study of complications of pulmonary artery catheterizations in 500 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Pulmonary Artery Catheter Consensus conference: consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Left Main Coronary Artery Stenosis: Hemodynamic Monitoring to Reduce Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Bedside catheterization of the pulmonary artery: risks compared with benefits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

inferred from DOI database lookup

7 January 2021

based on heuristic

A review of pulmonary artery catheterization in 6,245 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900322-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(98)00322-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9870839%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference